No abstract available
MeSH terms
-
Cerebral Arteries / diagnostic imaging
-
Cerebral Arteries / drug effects*
-
Cerebral Arteries / pathology
-
Cerebral Hemorrhage / chemically induced*
-
Cerebral Hemorrhage / diagnostic imaging
-
Cerebral Hemorrhage / pathology
-
Cyclic GMP / metabolism
-
Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy
-
Hypertension / physiopathology
-
Internal Capsule / blood supply
-
Internal Capsule / diagnostic imaging
-
Internal Capsule / pathology
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Paresis / chemically induced
-
Paresis / diagnostic imaging
-
Paresis / pathology
-
Phosphodiesterase 5 Inhibitors
-
Phosphodiesterase Inhibitors / adverse effects*
-
Piperazines / adverse effects*
-
Purines / adverse effects
-
Recovery of Function
-
Sildenafil Citrate
-
Sulfones / adverse effects*
-
Thalamus / blood supply
-
Thalamus / diagnostic imaging
-
Thalamus / pathology
-
Tomography, X-Ray Computed
-
Vasodilation / drug effects
-
Vasodilation / physiology
-
Vasodilator Agents / adverse effects*
Substances
-
Phosphodiesterase 5 Inhibitors
-
Phosphodiesterase Inhibitors
-
Piperazines
-
Purines
-
Sulfones
-
Vasodilator Agents
-
Sildenafil Citrate
-
Cyclic Nucleotide Phosphodiesterases, Type 5
-
Cyclic GMP